Table 1.
Dysregulation of miRNAs in Primary Biliary Cholangitis.
miRNAs | Tissue | Notes | Reference |
---|---|---|---|
miR-122a, miR-26a, miR-328, miR-299-5p | Liver | miR-122a/miR-26 DOWN miR-328/miR-299-5p UP |
Padgett et al., 2009 [39] |
miR-506 | Liver | miR-506 UP | Banales et al., 2012 [34] |
miR-15a-5p, miR-20a-5p, miR-140-3p, miR-106b-5p, miR-3654, miR-181a-5p | PBMCs | abnormal expression of 17 miRNAs that control cell differentiation and signal transduction | Qin et al., 2013 [40] |
hsa-miR-505-5p, hsa-miR-141-3p, has-miR-26b-5p | Sera | hsa-miR-505-3p/miR-197-3p DOWN | Ninomiya et al., 2013 [41] |
hsa-miR-122-5p, hsa-miR-141-3p, hsa-miR-26b-5p | Sera | disease biomarkers | Tan et al., 2014 [42] |
miRNA-122, miRNA-378, miRNA-4311, miRNA-4714-3p | Sera | risk stratification | Sakamoto et al., 2016 [43] |
miR-92a | Sera, PBMC | pathogenesis (Th17 cell differentiation) | Liang et al., 2016 [44] |